Navigation Links
NIH extends commitment to transformative research with 2008 Pioneer, New Innovator Awards
Date:9/21/2008

y to map the three-dimensional structure of the human genome as a means of identifying the molecular basis for many diseases, including various cancers.

  • Melanie D. Ohi, Ph.D., Vanderbilt University Medical Center assistant professor of cell and developmental biology, who will take a multidisciplinary approach toward understanding the structure and function of large molecular complexes called spliceosomes.

  • Karin S. Pfennig, Ph.D., University of North Carolina, Chapel Hill, assistant professor of biology, who will use an experimental approach to understand how an individual's health status and external environment influence his or her behavior.

  • Miguel Ramalho-Santos, Ph.D., University of California, San Francisco, assistant professor of obstetrics, gynecology and reproductive sciences and researcher in the Institute for Regeneration Medicine, who will study the control and function of stem cell pluripotency, which has implications for regenerative medicine and cancer biology.

  • Samara Reck-Peterson, Ph.D., Harvard Medical School assistant professor of cell biology, who will couple genetics with biophysics to discover biomedically important molecules that control how molecular motors deliver diverse cargo to the right place at the right time within cells.

  • Erik M. Shapiro, Ph.D., Yale University School of Medicine assistant professor of diagnostic radiology and biomedical engineering, who will use cellular and functional magnetic resonance imaging to aid in the development of novel strategies for manipulating stem and progenitor cell migration in the brain, particularly in response to injury and disease.

  • William M. Shih, Ph.D., Dana-Farber Cancer Institute assistant professor of biological chemistry and molecular pharmacology, who will develop tools for atomic-resolution imaging of membrane proteins to enable structure-based drug design.

  • Amy J. Wagers, Ph.D., Joslin Diabetes Center
    '/>"/>

  • Contact: Ann Dieffenbach
    dieffena@nigms.nih.gov
    301-496-7301
    NIH/National Institute of General Medical Sciences
    Source:Eurekalert

    Page: 1 2 3 4 5 6 7 8 9

    Related biology news :

    1. DOE JGI extends the capabilities of the Integrated Microbial Genome System
    2. Successful cooperation extends Dragon Program
    3. Thinking makes it so: Science extends reach of prosthetic arms
    4. FIJI Water announces sustainable growth initiative with commitment to help mitigate climate change
    5. U of M researchers identify gene linked to common ailment in labrador retrievers
    6. Friendly bacteria protect against type 1 diabetes, Yale researchers find
    7. Life Sciences Discovery Fund advances latest research proposals
    8. Using novel tool, UD researchers dig through cell trash and find treasure
    9. Longevity, cancer and diet connected: New research in worms could apply to humans
    10. Research pushes back history of crop development 10,000 years
    11. Nanotechnology: A brave new world requires bold new research approaches
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/20/2015)... The announcement comes as demand for fire ... Ireland,s foremost records management company, has ... an impressive track record of clients within the first 12 ... management sector in Dubai . As a ... employ a further eight staff members at its Irish headquarters. ...
    (Date:4/14/2015)... 14, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces that ... 2015 New York Design Awards under the category  ,Product ... City Design Awards are part of a global multi-disciplinary ... ratings from the marketplace, industry and judging panel. Winners ...
    (Date:4/10/2015)... April 10, 2015 Research and ... the "Security Competitive Profiles - NEC" report ... NEC will continue to supply a range ... market, with a company focus on the development of ... Winning opportunities in the Asia-Pacific ...
    Breaking Biology News(10 mins):Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3NEC Security Competitive Profile 2015 2
    ... are those that occur outside their natural range and ... can be plants, animals or microorganisms that are introduced ... tourism, travel or trade, or when domestic animals become ... the rising cost of invasive species on a global ...
    ... were once credited with magical healing powers but are now ... but the cause of numerous diseases such as diabetes if ... the vital role played by more complex sugars in many ... This all emerged in a recent workshop organised by ...
    ... (Jan. 16, 2008) -- Two major federal grants have been ... in New York City. Dr. Kenneth W. Griffin ... from the National Institute on Drug Abuse (NIDA) for research ... previously delivered to urban minority youth attending New York City ...
    Cached Biology News:Scientists call for urgent research into 'real' impacts of invasive species 2Scientists call for urgent research into 'real' impacts of invasive species 3ESF's workshop restores good name of sugar 2ESF's workshop restores good name of sugar 32 federal public health grants awarded to Weill Cornell Medical College 2
    (Date:5/27/2015)... , May 27, 2015  RXi Pharmaceuticals ... focused on discovering and developing innovative therapies primarily ... an update on the status of the Company,s ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ... 3,085 and 21 shares of Series A Preferred ...
    (Date:5/26/2015)... WORMS, GERMANY – May 26, 2015 ... announces that its manufacturing facility in Worms, Germany ... EXCiPACTâ„¢, an independent organization that certifies manufacturers, suppliers, ... All three Grace facilities that produce its SYLOID® ... have now received GMP certification, following the Curtis ...
    (Date:5/26/2015)... 26, 2015   Intrexon Corporation (NYSE: XON ... Gregory Frost , Ph.D., Senior Vice President and Head of ... Healthcare Conference on Wednesday, June 3 rd , at 1:30 ... New York City . About Intrexon Corporation ... the Bioindustrial Revolution with Better DNA ™ to create ...
    (Date:5/26/2015)... 26, 2015   PDI , a leader ... that Oakwood Healthcare in Dearborn, Mich. ... entry in Delivering the Difference ... excellence in building collaborative relationships between infection prevention ... facilities.  Oakwood Healthcare,s infection preventionist, ...
    Breaking Biology Technology:RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock 2RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock 3CORRECTION: Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2Intrexon to Present at the Jefferies 2015 Global Healthcare Conference 2PDI Announces Winner in Delivering the Difference Contest 2PDI Announces Winner in Delivering the Difference Contest 3
    ... N.J., April 15 Quest Diagnostics,Incorporated (NYSE: ... of the,previously disclosed federal government investigation related to ... manufacturing subsidiary closed,voluntarily in 2006. Quest Diagnostics cooperated ... , Quest Diagnostics will ...
    ... announced today that it,has completed the formation of ... existing group of Senior Advisers. NexBio recently ... investigational drug,candidate for influenza. The new CAB will ... medicine, helping the company to conduct advanced,product development ...
    ... BELGIUM, Wis., April 15 Mach One Corporation ... company, announces Monte B. Tobin, the President and ... One,s shareholders:Dear Fellow Shareholders:The mission of Mach One ... global wellness organizations that provide bio-based solutions to ...
    Cached Biology Technology:Quest Diagnostics Finalizes Previously Announced Settlement With Government Related to Test Kit Subsidiary Closed in 2006 2NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza 2NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza 3NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza 4Mach One CEO Letter to Shareholders 2Mach One CEO Letter to Shareholders 3Mach One CEO Letter to Shareholders 4